Cargando…
Congenital hyperinsulinism in infancy and childhood: challenges, unmet needs and the perspective of patients and families
BACKGROUND: Congenital hyperinsulinism (CHI) is the most common cause of persistent hypoglycemia in infants and children, and carries a considerable risk of neurological damage and developmental delays if diagnosis and treatment are delayed. Despite rapid advances in diagnosis and management, long-t...
Autores principales: | Banerjee, Indraneel, Raskin, Julie, Arnoux, Jean-Baptiste, De Leon, Diva D., Weinzimer, Stuart A., Hammer, Mette, Kendall, David M., Thornton, Paul S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858501/ https://www.ncbi.nlm.nih.gov/pubmed/35183224 http://dx.doi.org/10.1186/s13023-022-02214-y |
Ejemplares similares
-
Correction to: Congenital hyperinsulinism in infancy and childhood: challenges, unmet needs and the perspective of patients and families
por: Banerjee, Indraneel, et al.
Publicado: (2022) -
Extreme caution on the use of sirolimus for the congenital hyperinsulinism in infancy patient
por: Banerjee, Indraneel, et al.
Publicado: (2017) -
Atypical Forms of Congenital Hyperinsulinism in Infancy Are Associated With Mosaic Patterns of Immature Islet Cells
por: Han, Bing, et al.
Publicado: (2017) -
Enhanced Islet Cell Nucleomegaly Defines Diffuse Congenital Hyperinsulinism in Infancy but Not Other Forms of the Disease
por: Han, Bing, et al.
Publicado: (2016) -
Clinical Diversity in Focal Congenital Hyperinsulinism in Infancy Correlates With Histological Heterogeneity of Islet Cell Lesions
por: Craigie, Ross J., et al.
Publicado: (2018)